Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

WHO report reveals the worldwide failure to provide people with required mental health services

The World Health Organization's new Mental Health Atlas paints a disappointing picture of a worldwide failure to provide people with the mental health services they need, at a time when the COVID-19 pandemic is highlighting a growing need for mental health support.

11 Oct 2021

Mental health disorders in adolescents linked to long-term exclusion from education, labor market

Adolescents who had received a mental health disorder diagnosis were often excluded from the labor market and education as young adults.

8 Oct 2021

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

With the help of cutting-edge computer programs, researchers at the Icahn School of Medicine at Mount Sinai went through the genetic and medical records of more than 8,000 schizophrenia patients.

6 Sep 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published.

22 Jul 2021

Psychiatric patients have higher odds of hospitalization and death following COVID-19

In the largest systematic review and meta-analysis to date on COVID-19 outcomes in individuals with psychiatric disorders, the odds of dying or being hospitalized following COVID-19 infection were determined to be twice as high in comparison to persons without mental disorders.

16 Jul 2021

UK study finds brain or nerve complications in 1 in 20 of children hospitalized with COVID-19

Although the risk of a child being admitted to hospital due to COVID-19 is small, a new UK study has found that around 1 in 20 of children hospitalized with COVID-19 develop brain or nerve complications linked to the viral infection.

16 Jul 2021

Disruption in blood clotting and the first line immune system could contribute to psychosis

A scientific review has found evidence that a disruption in blood clotting and the first line immune system could be contributing factors in the development of psychosis.

16 Jul 2021

Study opens the door to improved treatment for psychosis sufferers

University of Otago scientists have opened the door to improved treatment of brain dysfunction which causes psychosis.

15 Jul 2021

About 4 in 100 COVID-19 hospitalized children may develop neurological complications, a study finds

In a recently published article in The Lancet’s Child & Adolescent Health, scientists have described in detail neurological and psychiatric manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. As mentioned in the study, an estimated prevalence of infection-related neurological complications and pediatric inflammatory multisystem syndrome in hospitalized children and adolescents is about 3.8 cases per 100 patients.

15 Jul 2021

Scientists identify abnormal neural replay of memories in people with schizophrenia

Neuroscientists at UCL have, for the first time, identified abnormalities in the way memories are 'replayed' in the brains of people with schizophrenia; researchers say the pathbreaking study provides an entirely new basis for explaining many of the condition's core symptoms.

30 Jun 2021

Patient-psychotherapist matching improves outcomes of mental health treatment

In first-of-its kind research led by a University of Massachusetts Amherst psychotherapy researcher, mental health care patients matched with therapists who had a strong track record of treating the patients' primary concerns had better results than patients who were not so matched.

29 Jun 2021

New project aims to identify quantitative biological features common across diseases

Building on the success of innovative research by the PRISM project, the Innovative Medicine Initiative 2, a joint undertaking between the EU and the European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the program with funding for a new project to explore the underlying biology of Alzheimer's disease, schizophrenia and Major Depressive Disorder (MDD).

23 Jun 2021

Proven treatment for psychosis has been recognized as standard of care

Most people with a serious mental illness like schizophrenia will not obtain adequate care. Many end up in correctional facilities on medication or become homeless.

18 Jun 2021

Cinnamon compound could be useful supplement to dexamethasone in COVID-19 treatment

Researchers in Germany and the United States have conducted a study showing that supplementing dexamethasone treatment with Ceylon cinnamon in cases of coronavirus disease 2019 (COVID-19) may allow dexamethasone to be administered at lower doses, thereby avoiding the side effects that occur with high doses of the steroid.

17 Jun 2021

Immune system dysfunction can alter the link between cannabis use and psychosis

The presence of pro-inflammatory cytokines in the blood can boost the effects of daily cannabis use and heighten the risk of developing psychosis in adulthood.

16 Jun 2021

Treatment-resistant depression relieved by laughing gas

Researchers at the Washington University School of Medicine in St. Louis and the University of Chicago have found that a single, one-hour treatment involving the inhalation of a mixture of oxygen and the anesthetic drug nitrous oxide, also known as laughing gas, can improve symptoms of depression in people resistant to treatment.

15 Jun 2021

A single blood-based biomarker can help indicate underlying neurodegeneration

Levels of a protein called neurofilament light chain (NfL) in the blood can identify those who might have neurodegenerative diseases such as Down's syndrome dementia, motor neuron disease (ALS) and frontotemporal dementia, when clinical symptoms are not definitive

7 Jun 2021

Methamphetamine users more susceptible to have medical, mental, and substance use issues

People who use methamphetamine are nearly twice as likely to have medical multimorbidity, and over three times as likely to have a mental illness.

2 Jun 2021

Research offers new hope for people affected by the microdeletion of chromosome 22

One person in 2000 suffers from a microdeletion of chromosome 22 that can lead to the development of psychotic disorders, such as schizophrenia, in adolescence.

1 Jun 2021

Psychosis News and Research

Further Reading

WHO report reveals the worldwide failure to provide people with required mental health services

Mental health disorders in adolescents linked to long-term exclusion from education, labor market

Polygenic risk score no better at predicting psychosis outcomes than written reports, study finds

Study explores ‘brain fog’ following COVID-19

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Psychiatric patients have higher odds of hospitalization and death following COVID-19

UK study finds brain or nerve complications in 1 in 20 of children hospitalized with COVID-19

Disruption in blood clotting and the first line immune system could contribute to psychosis

Study opens the door to improved treatment for psychosis sufferers

About 4 in 100 COVID-19 hospitalized children may develop neurological complications, a study finds

Scientists identify abnormal neural replay of memories in people with schizophrenia

Patient-psychotherapist matching improves outcomes of mental health treatment

New project aims to identify quantitative biological features common across diseases

Proven treatment for psychosis has been recognized as standard of care

Cinnamon compound could be useful supplement to dexamethasone in COVID-19 treatment

Immune system dysfunction can alter the link between cannabis use and psychosis

Treatment-resistant depression relieved by laughing gas

A single blood-based biomarker can help indicate underlying neurodegeneration

Methamphetamine users more susceptible to have medical, mental, and substance use issues

Research offers new hope for people affected by the microdeletion of chromosome 22

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News